[Skip to Content]
[Skip to Content Landing]
Views 171
Citations 0
Comment & Response
June 10, 2020

Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research

Author Affiliations
  • 1Department of Dermatology, Broward Health, Fort Lauderdale, FL
  • 2Department of Population Health Sciences, University of Utah, Salt Lake City
JAMA Dermatol. Published online June 10, 2020. doi:10.1001/jamadermatol.2020.1310

To the Editor We read with interest the recent article by Cheraghlou et al1 comparing overall survival among patients with stage I melanoma receiving Mohs micrographic surgery (MMS) or wide margin excision (WME). Although we agree that these data potentially support the use of MMS in patients with stage I tumors, we point out an erroneous use of the term noninferiority and suggest a significant limitation not mentioned.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words